Teva Pharmaceuticals CEO Richard Francis says the company is moving shares from ADRs to direct NYSE trading, a change that will affect what investors see on the market.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
